Accelerate Diagnostics Stock

Accelerate Diagnostics Debt

Delisted

The Debt of Accelerate Diagnostics (AXDX) as of Sep 12, 2026 is 63.47 M USD. In the previous year, Debt was 37.67 M USD — a change of 68.48% (higher).

Debt

63.47 MUSD

YoY

68.48%

Last updated:

In 2026, Accelerate Diagnostics's total debt was 63.47 M USD, a 68.48% change from the 37.67 M USD total debt recorded in the previous year.

The Accelerate Diagnostics Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2017
0.00 USD
Jan 1, 2018
120.10 M USD
Jan 1, 2019
130.00 M USD
Jan 1, 2020
146.40 M USD
Jan 1, 2021
108.10 M USD
Jan 1, 2022
75.20 M USD
Jan 1, 2023
37.67 M USD
Jan 1, 2024
63.47 M USD
The Accelerate Diagnostics Debt history
YEARDebtYoY
63.47 MUSD+68.48%
37.67 MUSD-49.90%
75.20 MUSD-30.43%
108.10 MUSD-26.16%
146.40 MUSD+12.62%
130.00 MUSD+8.24%
120.10 MUSD—
0.00USD—
0.00USD—
0.00USD-100.00%
200,000.00USD—
Access this data via the Eulerpool API
Get Free API Key

Accelerate Diagnostics Stock analysis

What does Accelerate Diagnostics do? Accelerate Diagnostics is one of the most popular companies on Eulerpool.

Debt Details

Understanding Accelerate Diagnostics's Debt Structure

Accelerate Diagnostics's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Accelerate Diagnostics's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Accelerate Diagnostics’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Accelerate Diagnostics’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Accelerate Diagnostics stock

Debt of Accelerate Diagnostics is 63.47 M USD in 2026.

Debt of Accelerate Diagnostics changed from 37.67 M USD to 63.47 M USD, representing a 68.48% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Debt Accelerate Diagnostics since 2006 – with annual values, charts, and detailed analysis.

Debt's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's Accelerate Diagnostics historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Accelerate Diagnostics

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Accelerate Diagnostics